4-Bromo-2,6-difluoroanisole - CAS 104197-14-0
Catalog: |
BB001350 |
Product Name: |
4-Bromo-2,6-difluoroanisole |
CAS: |
104197-14-0 |
Synonyms: |
5-bromo-1,3-difluoro-2-methoxybenzene; 5-bromo-1,3-difluoro-2-methoxybenzene |
IUPAC Name: | 5-bromo-1,3-difluoro-2-methoxybenzene |
Description: | 4-Bromo-2,6-difluoroanisole (CAS# 104197-14-0) is a useful research chemical for organic synthesis. |
Molecular Weight: | 223.01 |
Molecular Formula: | C7H5BrF2O |
Canonical SMILES: | COC1=C(C=C(C=C1F)Br)F |
InChI: | InChI=1S/C7H5BrF2O/c1-11-7-5(9)2-4(8)3-6(7)10/h2-3H,1H3 |
InChI Key: | CDOQKISJPOWBKC-UHFFFAOYSA-N |
Boiling Point: | 80 °C (15 torr) |
Density: | 1.615 g/cm3 |
Storage: | Sealed in dry, 2-8 °C |
MDL: | MFCD01631351 |
LogP: | 2.73590 |
GHS Hazard Statement: | H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation] |
Precautionary Statement: | P261, P264, P271, P280, P302+P352, P304+P340, P305+P351+P338, P312, P321, P332+P313, P337+P313, P362, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
WO-2020189540-A1 | Method for preparing aromatic amino acid derivative | 20190315 |
US-2019317402-A1 | Salt, acid generator, resist composition and method for producing resist pattern | 20180412 |
WO-2019198024-A1 | 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication | 20180411 |
EP-3774775-A1 | 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication | 20180411 |
US-2021024503-A1 | 4-oxo-3,4-dihydroquinazoline compounds as inhibitors of human immunodeficiency virus replication | 20180411 |
Complexity: | 122 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 221.94918 |
Formal Charge: | 0 |
Heavy Atom Count: | 11 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 221.94918 |
Rotatable Bond Count: | 1 |
Topological Polar Surface Area: | 9.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.8 |
-
Catalog: BB044292
(+)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB054256
((2S,4R)-2-((1H-1,2,4-Triazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methanol
Detail
-
Catalog: BB044156
(-)-2,10-(3,3-dichlorocamphorsultam)
Detail
-
Catalog: BB030539
(±)-2,3-Dibromobutane
Detail
-
Catalog: BB054190
(-)-(8,8-Dichlorocamphorylsulfonyl)oxaziridine
Detail
-
Catalog: BB045655
((5-[(4-Chloro-3-methyl-1H-pyrazol-1-yl)methyl]-4-ethyl-4H-1,2,4-triazol-3-yl)thio)acetic acid
Detail
-
Catalog: BB051699
(1-(2,2-Difluoroethyl)-1H-pyrazol-4-yl)methanamine hydrochloride
Detail
-
Catalog: BB079620
((4-bromo-3-(bromomethyl)butoxy)methyl)benzene
Detail
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS